Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | AZD5335 |
| Trade Name | |
| Synonyms | AZD 5335|AZD-5335|Torvutatug Samrotecan |
| Drug Descriptions |
AZD5335 is an antibody-drug conjugate (ADC) comprising an antibody targeting FOLR1 (FRalpha) linked to a topoisomerase 1 inhibitor, which potentially inhibits tumor growth (Cancer Res (2023) 83 (8_Supplement): LB025). |
| DrugClasses | FOLR1-targeted Therapy 24 |
| CAS Registry Number | 2975630-26-1 |
| NCIT ID | C200057 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| AZD5335 | AZD5335 | 0 | 2 |
| AZD5335 + AZD9574 | AZD5335 AZD9574 | 0 | 1 |
| AZD5335 + AZD9574 + Bevacizumab | AZD5335 AZD9574 Bevacizumab | 0 | 1 |
| AZD5335 + AZD9574 + Pembrolizumab | AZD5335 AZD9574 Pembrolizumab | 0 | 1 |
| AZD5335 + Bevacizumab | AZD5335 Bevacizumab | 0 | 1 |
| AZD5335 + Bevacizumab + Carboplatin | AZD5335 Bevacizumab Carboplatin | 0 | 1 |
| AZD5335 + Carboplatin | AZD5335 Carboplatin | 0 | 1 |
| AZD5335 + Itraconazole | AZD5335 Itraconazole | 0 | 1 |
| AZD5335 + Pembrolizumab | AZD5335 Pembrolizumab | 0 | 1 |
| AZD5335 + Saruparib | AZD5335 Saruparib | 0 | 1 |